• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Pharma
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Oncology
    • Supply Chain
  • Awards
    • Outsourcing Awards
    • Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Pharma
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Oncology
    • Supply Chain
  • Awards
    • Outsourcing Awards
    • Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

bladder cancer

US Supreme Court
Pharma

SCOTUS order advances racketeering case involving Takeda, Lilly

The Supreme Court denied Takeda and Eli Lilly's bid to stop the case from moving forward.
Zoey Becker Mar 24, 2026 8:45am
Combine

Padcev-Keytruda combo wins in MIBC amid evolving landscape

Feb 27, 2026 10:00am
An arrow incrementally going up stairs before pointing straight up Blue background

Keytruda, Padcev keep winning streak in bladder cancer

Dec 17, 2025 9:53am
On target clinical trial success bullseye score

ImmunityBio's Anktiva hits the mark in bladder cancer subtype

Dec 17, 2025 9:35am
FDA

Padcev, Keytruda combo scores game-changing FDA nod

Nov 21, 2025 1:22pm
On target clinical trial success bullseye score

Keytruda, Padcev cut risk of death by 50% in MIBC patient subset

Oct 18, 2025 10:30am

Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Biotech
    • Fierce Healthcare
    • Fierce Pharma
  • Our Events
    • Life Sciences Events
©2026 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings